Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
AssigneeCalifornia Institute of Technology
InventorsYue Shen, Sarkis K. Mazmanian
Life of this patent
Estimating the term…
Abstract
PSA is delivered to the host by outer membrane vesicles (OMVs), secretion structures that target bacterial molecules to host cells. Purified OMVs direct the in vitro differentiation of functional Tregs with potent suppressive activity in a PSA dependent manner. Treatment of animals with OMVs containing PSA prevents experimental colitis and suppresses pro-inflammatory cytokine responses in the gut, and indicate that compositions, medicaments, and methods useful for the treatment of inflammation, and more particularly, inflammatory bowel diseases.
Claims14
1-24. (canceled)
A method of treating an inflammatory disease or inflammation in an individual, comprising
- administering an effective amount of a pharmaceutical composition comprising an outer membrane vesicle comprising a Polysaccharide A (PSA);
- and a pharmaceutically acceptable carrier,
- wherein the composition is in the form of a tablet, granule, powder, solution, emulsion or suspension.
A method for directing the differentiation of a functional regulatory T cell (Treg) with potent suppressive activity, comprising
- contacting dendritic cells with a pharmaceutical composition comprising an outer membrane vesicle of B. fragilis comprising a Polysaccharide A (PSA);
- and a pharmaceutically acceptable carrier,
- wherein the composition is in the form of a tablet, granule, powder, solution, emulsion or suspension;
- and
- wherein the composition programs the dendritic cells to induce differentiation of the Treg cell.
Dependencies are inferred from the claim text.